ISSN 1308-7649 | E-ISSN 2148-3817
Case Report
Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment
1 Department Neuroscience Mental Health and Sensory Organs (NESMOS), Sapienza University, Rome, Italy  
J Int Adv Otol 2017; 13: 285-288
DOI: 10.5152/iao.2017.2772
This article was viewed 210 times, downloaded 93 times

Key Words: Intralabyrinthine schwannoma, vertigo, intratympanic gentamicin, sensorineural hearing loss
Abstract

Intralabyrinthine schwannoma (ILS) is a rare benign tumor that affects the ends of cochlear and vestibular nerves. In a majority of the cases, it occurs with unilateral progressive sensorineural hearing loss. Less frequent symptoms include tinnitus, imbalance, vertigo, or fullness. The advent of magnetic resonance imaging allows early diagnosis and enables an appropriate therapeutic protocol. This report describes a case of intravestibular schwannoma, with fluctuating hearing loss and intractable vertigo, treated with intratympanic gentamicin. The patient was a 28-year-old woman with intractable vertigo and fluctuating left-side hearing loss caused by left intravestibular schwannoma. Because surgery was temporarily rejected by the patient, a single dose of intratympanic gentamicin was administered. Following this, the patient showed a significant improvement in the symptoms. However, moderate to flat sensorineural hearing loss was also observed. Intratympanic gentamicin infiltration is a valid therapeutic option for patients with ILS, affected by intractable vertigo, when the patient refuses surgery. 

 

 

Cite this article as: Covelli E, Volpini L, Filippi C, Tarantini S, Marrone V, Monini S, et al. Intralabyrinthine Vestibular Schwannoma Responsive to Intratympanic Gentamicin Treatment. J Int Adv Otol 2017; 13: 285-8.

Key Words
Authors
All
Author's Corner
Reviewer's Corner
Survey
AVES | Copyright © 2017 The European Academy of Otology and Neurotology | Latest Update: 16.08.2017